Literature DB >> 30946190

Comparing Complications and Costs of Total Hip Arthroplasty and Hemiarthroplasty for Femoral Neck Fractures: A Propensity Score-Matched, Population-Based Study.

Bheeshma Ravi1,2, Daniel Pincus1,3, Hayat Khan1, David Wasserstein1,2, Richard Jenkinson1,2,3, Hans J Kreder1,2,3.   

Abstract

BACKGROUND: Although the prevalence of displaced femoral neck fractures in the elderly population is increasing worldwide, there remains controversy as to whether these injuries should be managed with hemiarthroplasty or total hip arthroplasty. Although total hip arthroplasties result in better function, they are more expensive and may have higher complication rates. Our objective was to compare the complication rates and health-care costs between hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures in the elderly population.
METHODS: A population-based, retrospective cohort study was performed on adults (≥60 years of age) undergoing either hemiarthroplasty or total hip arthroplasty for hip fracture between April 1, 2004, and March 31, 2014. We excluded patients who resided in long-term care facilities prior to the injury and those who were discharged to these facilities after the surgical procedure. Patients who underwent a hemiarthroplasty and those who underwent a total hip arthroplasty were matched using a propensity score encompassing patient demographic characteristics, patient comorbidities, and provider factors. After matching, we compared the rates of medical and surgical complications, as well as the perioperative and postoperative health-care costs in the year following the surgical procedure. The primary outcome was the occurrence of a medical complication (acute myocardial infarction, deep venous thrombosis, pulmonary embolism, ileus, pneumonia, renal failure) within 90 days or a surgical complication (dislocation, infection, revision surgical procedure) within 1 year. Additionally, we examined the change in health-care costs in the year following the surgical procedure, including costs associated with the index admission, relative to the year before the surgical procedure.
RESULTS: Among 29,121 eligible patients, 2,713 (9.3%) underwent a total hip arthroplasty. After successfully matching 2,689 patients who underwent a total hip arthroplasty with those who underwent a hemiarthroplasty, the patients who underwent a total hip arthroplasty were at an increased risk for dislocation (1.7% compared with 1.0%; p = 0.02), but were at a decreased risk for revision (0.2% compared with 1.8%; p < 0.0001), relative to patients who underwent a hemiarthroplasty. Furthermore, the overall increase in the annual health-care expenditure in the year following the surgical procedure was approximately $2,700 in Canadian dollars lower in patients who underwent a total hip arthroplasty (p < 0.001).
CONCLUSIONS: Among elderly patients with displaced femoral neck fractures, total hip arthroplasty was associated with lower rates of revision surgical procedures and reduced health-care costs during the index admission and in the year following the surgical procedure, relative to hemiarthroplasty. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2019        PMID: 30946190     DOI: 10.2106/JBJS.18.00539

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  23 in total

1.  Low conversion rates toward total hip arthroplasty after hemiarthroplasty in patients under 75 years of age.

Authors:  P P Schmitz; J L C van Susante; M P Somford
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-19

2.  Comparing total hip arthroplasty and hemiarthroplasty in the treatment of hip fracture.

Authors:  Nicholas J Tucker; Atul F Kamath
Journal:  Ann Transl Med       Date:  2019-12

Review 3.  A Systematic Review of Propensity Score Matching in the Orthopedic Literature.

Authors:  Gabriel R Arguelles; Max Shin; Drake G Lebrun; Christopher J DeFrancesco; Peter D Fabricant; Keith D Baldwin
Journal:  HSS J       Date:  2022-04-04

Review 4.  The Global Burden of Surgical Management of Osteoporotic Fractures.

Authors:  Seth M Tarrant; Zsolt J Balogh
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

5.  Total Hip Arthroplasty Outperforms Hemiarthroplasty in Patients Aged 65 Years and Older: A Propensity-Matched Study of Short-Term Outcomes.

Authors:  Jared A Warren; Kavin Sundaram; Hiba K Anis; Nicolas S Piuzzi; Carlos A Higuera; Atul F Kamath
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-09-20

6.  Hip Fractures: Relevant Anatomy, Classification, and Biomechanics of Fracture and Fixation.

Authors:  Young Lu; Harmeeth S Uppal
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-07-03

7.  [Risk factors analysis for postoperative mortality of elderly patients with femoral neck fracture undergoing hemiarthroplasty].

Authors:  Panpan Lu; Tian Xie; Guangchun Dai; Yingjuan Li; Jihong Zou; Hui Chen; Yunfeng Rui
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-02-15

Review 8.  Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 1. Diagnosis and risk factors.

Authors:  Srihatach Ngarmukos; Kang-Il Kim; Siwadol Wongsak; Thanainit Chotanaphuti; Yutaka Inaba; Cheng-Fong Chen; David Liu
Journal:  Knee Surg Relat Res       Date:  2021-06-19

9.  Direct Anterior Approach Versus Posterolateral Approach for Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures in Geriatric Patients.

Authors:  Cagri Neyisci; Yusuf Erdem; Ahmet Burak Bilekli; Dogan Bek
Journal:  Med Sci Monit       Date:  2020-01-21

10.  Study protocol: HipSTHeR - a register-based randomised controlled trial - hip screws or (total) hip replacement for undisplaced femoral neck fractures in older patients.

Authors:  Olof Wolf; Pontus Sjöholm; Nils P Hailer; Michael Möller; Sebastian Mukka
Journal:  BMC Geriatr       Date:  2020-01-21       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.